thiophenes has been researched along with tiotropium bromide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Laustsen, G; Wimmett, L | 1 |
| Bachhawat, P; Bures, MG; Christopoulos, A; Evans, DA; Felder, CC; Feng, D; Kobilka, BK; Kobilka, TS; Leach, K; Nawaratne, V; Sexton, PM; Sun, B; Thal, DM; Weis, WI | 1 |
1 review(s) available for thiophenes and tiotropium bromide
| Article | Year |
|---|---|
2004 drug approval highlights: FDA update.
Topics: Administration, Cutaneous; Amlodipine; Anti-Bacterial Agents; Antidepressive Agents; Bronchodilator Agents; Cardiovascular Agents; Drug Approval; Drug Combinations; Duloxetine Hydrochloride; Eplerenone; Estradiol; Excitatory Amino Acid Antagonists; Female; Gastrointestinal Agents; Heptanoic Acids; Humans; Ketolides; Male; Memantine; Osteoporosis, Postmenopausal; Pyrroles; Rifamycins; Rifaximin; Scopolamine Derivatives; Spironolactone; Thiophenes; Tiotropium Bromide; United States | 2005 |
1 other study(ies) available for thiophenes and tiotropium bromide
| Article | Year |
|---|---|
Crystal structures of the M1 and M4 muscarinic acetylcholine receptors.
Topics: Acetylcholine; Allosteric Regulation; Allosteric Site; Alzheimer Disease; Crystallization; Crystallography, X-Ray; Drug Inverse Agonism; Humans; Models, Molecular; Nicotinic Acids; Receptor, Muscarinic M1; Receptor, Muscarinic M4; Schizophrenia; Static Electricity; Substrate Specificity; Surface Properties; Thiophenes; Tiotropium Bromide | 2016 |